Securing the pharmaceutical supply chain: issues and perspectives
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
Nova Science Publishers, Inc.
[2015]
|
| Schriftenreihe: | Pharmacology-research, safety testing, and regulation series
|
| Schlagworte: | |
| Online-Zugang: | FLA01 |
| Beschreibung: | Description based on online resource; title from PDF title page (EBSCO, viewed December 22, 2014) |
| Beschreibung: | 1 online resource |
| ISBN: | 9781634634496 1634634497 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045357950 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 181212s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9781634634496 |9 978-1-63463-449-6 | ||
| 020 | |a 1634634497 |9 1-63463-449-7 | ||
| 035 | |a (ZDB-4-EBU)ocn898279168 | ||
| 035 | |a (OCoLC)898279168 | ||
| 035 | |a (DE-599)BVBBV045357950 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 338.476151 |2 23 | |
| 245 | 1 | 0 | |a Securing the pharmaceutical supply chain |b issues and perspectives |c Lenora White, editor |
| 264 | 1 | |a New York |b Nova Science Publishers, Inc. |c [2015] | |
| 264 | 4 | |c 2015 | |
| 300 | |a 1 online resource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pharmacology-research, safety testing, and regulation series | |
| 500 | |a Description based on online resource; title from PDF title page (EBSCO, viewed December 22, 2014) | ||
| 505 | 8 | |a The drug package that a community pharmacist hands to a patient, or a hospital pharmacist sends to a patient's bedside, or a physician administers in the medical office has reached the end of a complicated path. That path is called a supply or distribution chain. The upstream portion of the chain includes the journey of each active and inactive ingredient and their chemical components to the manufacturer that creates the finished drug product. The downstream chain, which this report addresses, includes the repackagers, wholesale distributors, associated storage and transport companies, and, fi | |
| 650 | 7 | |a BUSINESS & ECONOMICS / Industries / General |2 bisacsh | |
| 650 | 7 | |a Drug adulteration / Prevention |2 fast | |
| 650 | 4 | |a Pharmaceutical industry |x Security measures |z United States |a Product counterfeiting |z United States |x Prevention |a Drug adulteration |z United States |x Prevention | |
| 700 | 1 | |a White, Lenora |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a White, Lenora |t Securing the Pharmaceutical Supply Chain : Issues and Perspectives |d Hauppauge : Nova Science Publishers, Inc.,c2014 |z 9781634634489 |
| 912 | |a ZDB-4-EBU | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030744542 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=928684 |l FLA01 |p ZDB-4-EBU |q FLA_PDA_EBU |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804179188896235520 |
|---|---|
| any_adam_object | |
| author2 | White, Lenora |
| author2_role | edt |
| author2_variant | l w lw |
| author_facet | White, Lenora |
| building | Verbundindex |
| bvnumber | BV045357950 |
| collection | ZDB-4-EBU |
| contents | The drug package that a community pharmacist hands to a patient, or a hospital pharmacist sends to a patient's bedside, or a physician administers in the medical office has reached the end of a complicated path. That path is called a supply or distribution chain. The upstream portion of the chain includes the journey of each active and inactive ingredient and their chemical components to the manufacturer that creates the finished drug product. The downstream chain, which this report addresses, includes the repackagers, wholesale distributors, associated storage and transport companies, and, fi |
| ctrlnum | (ZDB-4-EBU)ocn898279168 (OCoLC)898279168 (DE-599)BVBBV045357950 |
| dewey-full | 338.476151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.476151 |
| dewey-search | 338.476151 |
| dewey-sort | 3338.476151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02341nmm a2200397zc 4500</leader><controlfield tag="001">BV045357950</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181212s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781634634496</subfield><subfield code="9">978-1-63463-449-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1634634497</subfield><subfield code="9">1-63463-449-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBU)ocn898279168</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)898279168</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045357950</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.476151</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Securing the pharmaceutical supply chain</subfield><subfield code="b">issues and perspectives</subfield><subfield code="c">Lenora White, editor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science Publishers, Inc.</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacology-research, safety testing, and regulation series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (EBSCO, viewed December 22, 2014)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The drug package that a community pharmacist hands to a patient, or a hospital pharmacist sends to a patient's bedside, or a physician administers in the medical office has reached the end of a complicated path. That path is called a supply or distribution chain. The upstream portion of the chain includes the journey of each active and inactive ingredient and their chemical components to the manufacturer that creates the finished drug product. The downstream chain, which this report addresses, includes the repackagers, wholesale distributors, associated storage and transport companies, and, fi</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Industries / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug adulteration / Prevention</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Security measures</subfield><subfield code="z">United States</subfield><subfield code="a">Product counterfeiting</subfield><subfield code="z">United States</subfield><subfield code="x">Prevention</subfield><subfield code="a">Drug adulteration</subfield><subfield code="z">United States</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">White, Lenora</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">White, Lenora</subfield><subfield code="t">Securing the Pharmaceutical Supply Chain : Issues and Perspectives</subfield><subfield code="d">Hauppauge : Nova Science Publishers, Inc.,c2014</subfield><subfield code="z">9781634634489</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBU</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030744542</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=928684</subfield><subfield code="l">FLA01</subfield><subfield code="p">ZDB-4-EBU</subfield><subfield code="q">FLA_PDA_EBU</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV045357950 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:15:54Z |
| institution | BVB |
| isbn | 9781634634496 1634634497 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030744542 |
| oclc_num | 898279168 |
| open_access_boolean | |
| physical | 1 online resource |
| psigel | ZDB-4-EBU ZDB-4-EBU FLA_PDA_EBU |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Nova Science Publishers, Inc. |
| record_format | marc |
| series2 | Pharmacology-research, safety testing, and regulation series |
| spelling | Securing the pharmaceutical supply chain issues and perspectives Lenora White, editor New York Nova Science Publishers, Inc. [2015] 2015 1 online resource txt rdacontent c rdamedia cr rdacarrier Pharmacology-research, safety testing, and regulation series Description based on online resource; title from PDF title page (EBSCO, viewed December 22, 2014) The drug package that a community pharmacist hands to a patient, or a hospital pharmacist sends to a patient's bedside, or a physician administers in the medical office has reached the end of a complicated path. That path is called a supply or distribution chain. The upstream portion of the chain includes the journey of each active and inactive ingredient and their chemical components to the manufacturer that creates the finished drug product. The downstream chain, which this report addresses, includes the repackagers, wholesale distributors, associated storage and transport companies, and, fi BUSINESS & ECONOMICS / Industries / General bisacsh Drug adulteration / Prevention fast Pharmaceutical industry Security measures United States Product counterfeiting United States Prevention Drug adulteration United States Prevention White, Lenora edt Erscheint auch als Druck-Ausgabe White, Lenora Securing the Pharmaceutical Supply Chain : Issues and Perspectives Hauppauge : Nova Science Publishers, Inc.,c2014 9781634634489 |
| spellingShingle | Securing the pharmaceutical supply chain issues and perspectives The drug package that a community pharmacist hands to a patient, or a hospital pharmacist sends to a patient's bedside, or a physician administers in the medical office has reached the end of a complicated path. That path is called a supply or distribution chain. The upstream portion of the chain includes the journey of each active and inactive ingredient and their chemical components to the manufacturer that creates the finished drug product. The downstream chain, which this report addresses, includes the repackagers, wholesale distributors, associated storage and transport companies, and, fi BUSINESS & ECONOMICS / Industries / General bisacsh Drug adulteration / Prevention fast Pharmaceutical industry Security measures United States Product counterfeiting United States Prevention Drug adulteration United States Prevention |
| title | Securing the pharmaceutical supply chain issues and perspectives |
| title_auth | Securing the pharmaceutical supply chain issues and perspectives |
| title_exact_search | Securing the pharmaceutical supply chain issues and perspectives |
| title_full | Securing the pharmaceutical supply chain issues and perspectives Lenora White, editor |
| title_fullStr | Securing the pharmaceutical supply chain issues and perspectives Lenora White, editor |
| title_full_unstemmed | Securing the pharmaceutical supply chain issues and perspectives Lenora White, editor |
| title_short | Securing the pharmaceutical supply chain |
| title_sort | securing the pharmaceutical supply chain issues and perspectives |
| title_sub | issues and perspectives |
| topic | BUSINESS & ECONOMICS / Industries / General bisacsh Drug adulteration / Prevention fast Pharmaceutical industry Security measures United States Product counterfeiting United States Prevention Drug adulteration United States Prevention |
| topic_facet | BUSINESS & ECONOMICS / Industries / General Drug adulteration / Prevention Pharmaceutical industry Security measures United States Product counterfeiting United States Prevention Drug adulteration United States Prevention |
| work_keys_str_mv | AT whitelenora securingthepharmaceuticalsupplychainissuesandperspectives |